Pyrazolo[1,5-A]Pyridine-3-Carboxylic Acids as Ephb and Vegfr2 Kinase Inhibitors
申请人:Imbach Patricia
公开号:US20080300245A1
公开(公告)日:2008-12-04
The invention relates to novel pyrazolo[1,5a]pyridine-3-carboxylic acid compounds of the formula
in which all of the variables are as defined in the specification, in free form or in salt form, to their preparation, to their use as medicaments and to medicaments comprising them.
Pyrazolo[1,5-a]pyridine-3-carboxylic acids as EphB and VEGFR2 kinase inhibitors
申请人:Novartis AG
公开号:US07795273B2
公开(公告)日:2010-09-14
The invention relates to novel pyrazolo[1,5-a]pyridine-3-carboxylic acid compounds of the formula
in which all of the variables are as defined in the specification, in free form or in salt form, to their preparation, to their use as medicaments and to medicaments comprising them.
PYRAZOLO[1,5-A]PYRIDINE-3-CARBOXYLIC ACIDS AS EPHB AND VEGFR2 KINASE INHIBITORS
申请人:Novartis AG
公开号:EP1963316A2
公开(公告)日:2008-09-03
US7795273B2
申请人:——
公开号:US7795273B2
公开(公告)日:2010-09-14
[EN] PYRAZOLO[1,5-A]PYRIDINE-3-CARBOXYLIC ACIDS AS EPHB AND VEGFR2 KINASE INHIBITORS<br/>[FR] ACIDES PYRAZOLO[1,5-A]PYRIDINE-3-CARBOXYLIQUES UTILISES EN TANT QU'INHIBITEURS DE LA EPHB ET VEGFR2 KINASE
申请人:NOVARTIS AG
公开号:WO2007065664A2
公开(公告)日:2007-06-14
[EN] The invention relates to novel pyrazolo[1,5-a]pyridine-3-carboxylic acid compounds of the Formula (I) in which all of the variables are as defined in the specification, in free form or in salt form, to their preparation, to their use as medicaments and to medicaments comprising them. [FR] La présente invention concerne de nouveaux composés de l'acide pyrazolo[1,5-a]pyridine-3-carboxylique répondant à la formule (I), toutes les variables étant telles que définies dans la description, présentés sous forme libre ou sous forme de sels. L'invention se rapporte également à leur préparation, à leur utilisation en tant que médicaments et aux médicaments comprenant lesdits composés.